Cargando…
Lymphoid and myeloid immune cell reconstitution after nicotinamide-expanded cord blood transplantation
Omidubicel (nicotinamide-expanded cord blood) is a potential alternative source for allogeneic hematopoietic cell transplantation (HCT) when an HLA-identical donor is lacking. A phase I/II trial with standalone omidubicel HCT showed rapid and robust neutrophil and platelet engraftment. In this study...
Autores principales: | de Koning, Coco, Tao, Weiyang, Lacna, Amelia, van Veghel, Karin, Horwitz, Mitchell E., Sanz, Guillermo, Jagasia, Madan H., Wagner, John E., Stiff, Patrick J., Hanna, Rabi, Cilloni, Daniela, Valcárcel, David, Peled, Tony, Galamidi Cohen, Einat, Goshen, Uri, Pandit, Aridaman, Lindemans, Caroline A., Jan Boelens, Jaap, Nierkens, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563413/ https://www.ncbi.nlm.nih.gov/pubmed/34312498 http://dx.doi.org/10.1038/s41409-021-01417-4 |
Ejemplares similares
-
Reconstitution of T Cell Subsets Following Allogeneic Hematopoietic Cell Transplantation
por: Dekker, Linde, et al.
Publicado: (2020) -
Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide
por: Horwitz, Mitchell E., et al.
Publicado: (2019) -
Therapeutic Drug Monitoring of Anti-Thymocyte Globulin in Allogeneic Stem Cell Transplantation: Proof of Concept
por: Meesters-Ensing, J.I., et al.
Publicado: (2022) -
Naive T Cells in Graft Versus Host Disease and Graft Versus Leukemia: Innocent or Guilty?
por: Dekker, Linde, et al.
Publicado: (2022) -
Clofarabine-fludarabine-busulfan in HCT for pediatric leukemia: an effective, low toxicity, TBI-free conditioning regimen
por: Versluijs, A. Birgitta, et al.
Publicado: (2022)